ARTICLE | Company News
Bayer, Kythera in deal for ATX-101
August 31, 2010 12:37 AM UTC
Kythera Biopharmaceuticals Inc. (Calabasas, Calif.) granted Bayer AG (Xetra:BAY) exclusive rights to co-develop and commercialize ATX-101 outside the U.S. and Canada. This year, the partners plan to b...